Anazolene
C26H19N3O10S3 — CID 19732
View drug profile → anazoleneData last refreshed: (MolForge compound catalog, from PubChem)
About Anazolene
Anazolene (PubChem CID 19732) has the molecular formula C26H19N3O10S3 and a molecular weight of 629.65 g/mol. Its IUPAC name is 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid.
Molecular Properties
| Compound Name | Anazolene |
|---|---|
| PubChem CID | 19732 |
| Molecular Formula | C26H19N3O10S3 |
| Molecular Weight | 629.65 g/mol |
| Exact Mass | 629.02 |
| IUPAC Name | 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid |
| SMILES | O=S(=O)(O)c1cc(O)c2c(/N=N/c3ccc(Nc4ccccc4)c4c(S(=O)(=O)O)cccc34)cc(S(=O)(=O)O)cc2c1 |
| InChI | InChI=1S/C26H19N3O10S3/c30-23-14-18(41(34,35)36)12-15-11-17(40(31,32)33)13-22(25(15)23)29-28-20-9-10-21(27-16-5-2-1-3-6-16)26-19(20)7-4-8-24(26)42(37,38)39/h1-14,27,30H,(H,31,32,33)(H,34,35,36)(H,37,38,39)/b29-28+ |
| InChIKey | QFVHZQCOUORWEI-ZQHSETAFSA-N |
| XLogP | 5.60 |
| TPSA | 220.09 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 629.65 |
| LogP ≤ 5 | 5.60 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 10 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'}, {'alert_name': 'Sulfonic_acid_2', 'substructure': 'N/A'} |
|---|
Related Compounds
Frequently Asked Questions
Browse: Molecules: A · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 19732 — identifiers, structure, computed properties (public domain)
- DrugCentral drug card 211 — approved-drug record (CC BY-SA 4.0)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.